The global optometry equipment market is valued at an estimated USD 4.5 billion in 2024 and is projected to reach USD 6.1 billion by 2029, at a CAGR of 6.4% during the forecast period. The three main factors propelling the growth of the optometry equipment market are the aging population, the rise in eye illnesses, and the rising cost of healthcare in emerging nations.

The retina and glaucoma examination products, general examination products, and cornea and cataract examination products comprise the type-based segments of the worldwide optometry equipment market. During the projected period, the optometry equipment market, with its focus on retina and glaucoma examination items, is anticipated to have the greatest growth rate and market share. This segment is growing at a significant rate mostly because to an increase in glaucoma and retinal illnesses.

Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14475790

Based on application, the optometry equipment market is divided into categories such as general examination, cataract, glaucoma, age-related macular degeneration, and other applications. Over the course of the projection period, the general examination category is anticipated to have a larger market share. In the upcoming years, factors including the growing prevalence of eye illnesses and the increased awareness of eye care are anticipated to fuel market expansion.

Hospitals, eye clinics, and other end users comprise the end user segment of the optometry equipment market. In terms of worldwide market share for optometry equipment in 2023, the clinics sector led. The segment’s market share is influenced by a large patient pool that is treated in clinics, an increasing number of private clinics and practitioners in emerging countries, and an increase in the prevalence of visual impairments among the elderly.

The optometry equipment market is segmented into four major regions—North America, Europe, the Asia Pacific and Rest of the World (Latin America, the Middle East & Africa and GCC Countries). Over the course of the forecast period, the Asia Pacific market is anticipated to develop at the greatest CAGR. The rising incidence of ocular illnesses, rising healthcare spending in certain APAC nations, and the existence of high-growing markets in the area are all factors contributing to this market’s rise. The positive regulatory climate in this area is also anticipated to fuel market expansion.

Carl Zeiss Meditec AG (Germany), Alcon (Switzerland), EssilorLuxottica (France), Topcon Corporation (Japan), Bausch Health Companies Inc. (Canada), NIDEK Co. Ltd. (Japan), Canon Inc. (Japan), Johnson and Johnson (US), HEINE Optotechnik (Germany), Revenio Group PLC (Finland), Haag-Streit Group (Switzerland), Heidelberg Engineering (Germany), Luneau Technology (France), Escalon Medical (US), Keeler Ltd. (UK), Reichert Technologies (US), Oculus Inc. (US), Kowa American Corporation (US), Ziemer Ophthalmic Systems AG (Switzerland), Huvitz (South Korea), Neitz Instruments Co. Ltd. (Japan), Rexxam Co. Ltd. (Japan), Rudolf-Riester GmbH (Germany), FREY (Poland), and Yeasn (China)

Recent Developments of Optometry Equipment Industry:

• In August 2023, Carl Zeiss launched the ZEISS trifocal technology on a glistening-free hydrophobic C-loop platform and a fully preloaded injector for safe and reliable implantation.
• In March 2022, Topcon Corporation launched SOLOS, an automatic lens analyzer that enables advanced, accurate, and efficient lens analysis at the touch of a button.
• In September 2023, Bauch + Lomb acquired XIIDRA to grow in the prescription dry eyes segment.
• In January 2023Bausch + Lomb acquired AcuFocus to expand its cataract surgical portfolio.